877 related articles for article (PubMed ID: 15068396)
21. Functional analysis of pre-mRNA splicing factor SF2/ASF structural domains.
Cáceres JF; Krainer AR
EMBO J; 1993 Dec; 12(12):4715-26. PubMed ID: 8223480
[TBL] [Abstract][Full Text] [Related]
22. Multiple ASF/SF2 sites in the human papillomavirus type 16 (HPV-16) E4-coding region promote splicing to the most commonly used 3'-splice site on the HPV-16 genome.
Somberg M; Schwartz S
J Virol; 2010 Aug; 84(16):8219-30. PubMed ID: 20519389
[TBL] [Abstract][Full Text] [Related]
23. Pre-mRNA splicing in the absence of an SR protein RS domain.
Zhu J; Krainer AR
Genes Dev; 2000 Dec; 14(24):3166-78. PubMed ID: 11124808
[TBL] [Abstract][Full Text] [Related]
24. A novel splicing regulator shares a nuclear import pathway with SR proteins.
Lai MC; Kuo HW; Chang WC; Tarn WY
EMBO J; 2003 Mar; 22(6):1359-69. PubMed ID: 12628928
[TBL] [Abstract][Full Text] [Related]
25. Multiple activities of the human splicing factor ASF.
Harper JE; Manley JL
Gene Expr; 1992; 2(1):19-29. PubMed ID: 1535526
[TBL] [Abstract][Full Text] [Related]
26. HIV Rev-dependent binding of SF2/ASF to the Rev response element: possible role in Rev-mediated inhibition of HIV RNA splicing.
Powell DM; Amaral MC; Wu JY; Maniatis T; Greene WC
Proc Natl Acad Sci U S A; 1997 Feb; 94(3):973-8. PubMed ID: 9023367
[TBL] [Abstract][Full Text] [Related]
27. Role of SR protein modular domains in alternative splicing specificity in vivo.
van Der Houven Van Oordt W; Newton K; Screaton GR; Cáceres JF
Nucleic Acids Res; 2000 Dec; 28(24):4822-31. PubMed ID: 11121472
[TBL] [Abstract][Full Text] [Related]
28. Genetic analysis of the SR protein ASF/SF2: interchangeability of RS domains and negative control of splicing.
Wang J; Xiao SH; Manley JL
Genes Dev; 1998 Jul; 12(14):2222-33. PubMed ID: 9679066
[TBL] [Abstract][Full Text] [Related]
29. The SR splicing factors ASF/SF2 and SC35 have antagonistic effects on intronic enhancer-dependent splicing of the beta-tropomyosin alternative exon 6A.
Gallego ME; Gattoni R; Stévenin J; Marie J; Expert-Bezançon A
EMBO J; 1997 Apr; 16(7):1772-84. PubMed ID: 9130721
[TBL] [Abstract][Full Text] [Related]
30. Subtle discrepancies of SF2/ASF ESE sequence motif among human tissues: A computational approach.
Siala O; Rebai A; Baklouti F; Fakhfakh F
Comput Biol Chem; 2010 Jun; 34(3):203-9. PubMed ID: 20637698
[TBL] [Abstract][Full Text] [Related]
31. Protein-protein interactions and 5'-splice-site recognition in mammalian mRNA precursors.
Kohtz JD; Jamison SF; Will CL; Zuo P; Lührmann R; Garcia-Blanco MA; Manley JL
Nature; 1994 Mar; 368(6467):119-24. PubMed ID: 8139654
[TBL] [Abstract][Full Text] [Related]
32. Inhibition by SR proteins of splicing of a regulated adenovirus pre-mRNA.
Kanopka A; Mühlemann O; Akusjärvi G
Nature; 1996 Jun; 381(6582):535-8. PubMed ID: 8632829
[TBL] [Abstract][Full Text] [Related]
33. Arginine/serine-rich protein interaction domain-dependent modulation of a tau exon 10 splicing enhancer: altered interactions and mechanisms for functionally antagonistic FTDP-17 mutations Delta280K AND N279K.
D'Souza I; Schellenberg GD
J Biol Chem; 2006 Feb; 281(5):2460-9. PubMed ID: 16308321
[TBL] [Abstract][Full Text] [Related]
34. The splicing factor-associated protein, p32, regulates RNA splicing by inhibiting ASF/SF2 RNA binding and phosphorylation.
Petersen-Mahrt SK; Estmer C; Ohrmalm C; Matthews DA; Russell WC; Akusjärvi G
EMBO J; 1999 Feb; 18(4):1014-24. PubMed ID: 10022843
[TBL] [Abstract][Full Text] [Related]
35. PSKH1, a novel splice factor compartment-associated serine kinase.
Brede G; Solheim J; Prydz H
Nucleic Acids Res; 2002 Dec; 30(23):5301-9. PubMed ID: 12466556
[TBL] [Abstract][Full Text] [Related]
36. The human splicing factors ASF/SF2 and SC35 possess distinct, functionally significant RNA binding specificities.
Tacke R; Manley JL
EMBO J; 1995 Jul; 14(14):3540-51. PubMed ID: 7543047
[TBL] [Abstract][Full Text] [Related]
37. Role of the modular domains of SR proteins in subnuclear localization and alternative splicing specificity.
Cáceres JF; Misteli T; Screaton GR; Spector DL; Krainer AR
J Cell Biol; 1997 Jul; 138(2):225-38. PubMed ID: 9230067
[TBL] [Abstract][Full Text] [Related]
38. Regulated tissue-specific expression of antagonistic pre-mRNA splicing factors.
Hanamura A; Cáceres JF; Mayeda A; Franza BR; Krainer AR
RNA; 1998 Apr; 4(4):430-44. PubMed ID: 9630249
[TBL] [Abstract][Full Text] [Related]
39. Phosphorylation status of the Kep1 protein alters its affinity for its protein binding partner alternative splicing factor ASF/SF2.
Robard C; Daviau A; Di Fruscio M
Biochem J; 2006 Nov; 400(1):91-7. PubMed ID: 16834570
[TBL] [Abstract][Full Text] [Related]
40. Eight nucleotide substitutions inhibit splicing to HPV-16 3'-splice site SA3358 and reduce the efficiency by which HPV-16 increases the life span of primary human keratinocytes.
Li X; Johansson C; Cardoso Palacios C; Mossberg A; Dhanjal S; Bergvall M; Schwartz S
PLoS One; 2013; 8(9):e72776. PubMed ID: 24039800
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
